EirGenix Inc. (TPE:6589)
48.40
-0.40 (-0.82%)
Oct 28, 2026, 1:30 PM CST
EirGenix Market Cap
EirGenix has a market cap or net worth of 14.45 billion as of October 28, 2026. It is the 15,364th most valuable company in the world and the 556th biggest in Taiwan. Its market cap has decreased by 29.18% in one year.
Market Cap
14.45B
Enterprise Value
13.30B
Revenue
1.21B
Global Rank
Country Rank
#556 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since November 23, 2016, EirGenix's market cap has increased from 4.56B to 14.45B, an increase of 217.16%. That is a compound annual growth rate of 12.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 14.45B | -22.58% |
| Dec 31, 2025 | 18.67B | -15.33% |
| Dec 31, 2024 | 22.05B | -28.29% |
| Dec 29, 2023 | 30.75B | -17.85% |
| Dec 30, 2022 | 37.43B | 11.81% |
| Dec 30, 2021 | 33.48B | 245.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CHO Pharma | 23.01B |
| Sunmax Biotechnology | 21.54B |
| Medigen Vaccine Biologics | 16.77B |
| TaiMed Biologics | 16.69B |
| Ever Supreme Bio Technology | 15.31B |
| Steminent Biotherapeutics | 14.50B |
| Gongwin Biopharm Holdings | 14.23B |
| ACRO Biomedical | 13.26B |